Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an Amendment No. 7 to Schedule 13G, reporting a 7.4% beneficial ownership stake in Cannae Holdings Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant 8% Stake in CareDx Inc.
BlackRock, Inc. has filed an amended Schedule 13G, confirming its continued beneficial ownership of 8.0% of CareDx Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Celldex Therapeutics, Disclosing 7.3% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, revealing a 7.3% beneficial ownership stake in Celldex Therapeutics, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 13 to its Schedule 13G, disclosing a 9.2% beneficial ownership stake in Chimera Investment Corporation as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Easterly Government Properties, Disclosing 16.6% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 7 to its Schedule 13G, reporting a 16.6% beneficial ownership stake in Easterly Government Properties Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 9.0% passive beneficial ownership stake in Enphase Energy Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.2% beneficial ownership stake in Evolution Petroleum Corporation's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.4% of the common stock of Fidelity National Information Services Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.8% Stake in 4D Molecular Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.8% of 4D Molecular Therapeutics Inc.'s Common Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.6% Passive Stake in ACM Research, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.6% beneficial ownership stake in ACM Research, Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 16 to its Schedule 13G, reporting a 5.9% beneficial ownership stake in AES Corporation's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 5.8% passive beneficial ownership stake in Stoke Therapeutics, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses Continued 7.9% Stake in Kosmos Energy Ltd.
BlackRock, Inc. has filed an Amendment No. 9 to Schedule 13G, reaffirming its beneficial ownership of 7.9% of Kosmos Energy Ltd.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, reporting a beneficial ownership of 11.8% of WillScot Holdings Corp.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, revealing a beneficial ownership of 10.7% of Element Solutions Inc's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.7% Stake in Ambac Financial Group
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 8.7% of Ambac Financial Group Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.9% Passive Stake in Fulgent Genetics
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 5.9% beneficial ownership in Fulgent Genetics, Inc. as a passive institutional investor.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Stake in Mueller Water Products, Inc. with 16.1% Ownership
BlackRock, Inc. has filed an amended Schedule 13G, reaffirming its substantial beneficial ownership of 16.1% in Mueller Water Products, Inc.'s Class A Stock.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 17.3% Stake in Ryman Hospitality Properties
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 17.3% beneficial ownership stake in Ryman Hospitality Properties, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.7% Passive Stake in Wabash National Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 8.7% of Wabash National Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.4% Passive Stake in Hain Celestial Group
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.4% beneficial ownership stake in Hain Celestial Group Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 6.3% beneficial ownership stake in Green Dot Corp's Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, confirming a continued beneficial ownership of 5.1% of Nabors Industries Ltd.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 18 to its Schedule 13G, reporting a continued beneficial ownership of 15.6% of iShares Trust Common Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an updated Schedule 13G, reporting a 7.6% beneficial ownership stake in Mativ Holdings, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.6% Passive Stake in Green Plains Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.6% beneficial ownership stake in Green Plains Inc. as of March 31, 2025, held for investment purposes in the ordinary course of business.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 13.5% beneficial ownership stake in JBT Marel Corp as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 13.0% beneficial ownership stake in NorthWestern Energy Group, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 11.6% of BorgWarner Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 11.6% in Freshpet, Inc. common stock as of March 31, 2025.